Back to Search
STEPHANIE REMICK, PHARMD
PHARMD
Pharmacist
NPI: 1902937949Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
26020561A(IN)
Research & Publications (20)
Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-up.
PMID 11279624·Am J Hematol·2001
3-trial
Human herpesvirus-8-associated disseminated angiosarcoma in an HIV-seronegative woman: report of a case and limited case-control virologic study in vascular tumors.
PMID 10856415·Am J Med·2000
5-case
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
PMID 19399502·Cancer Chemother Pharmacol·2009
3-trial
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors.
PMID 19011760·Invest New Drugs·2009
3-trial
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.
PMID 18414865·Cancer Chemother Pharmacol·2009
3-trial
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.
PMID 19265494·Thyroid·2009
3-trial
Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
PMID 19203845·Int J Radiat Oncol Biol Phys·2009
4-observational
Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant.
PMID 19536846·Am J Hematol·2009
3-trial
A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkers.
PMID 19417018·Clin Cancer Res·2009
3-trial
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.
PMID 18670776·Cancer Chemother Pharmacol·2009
3-trial
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.
PMID 19470940·J Clin Oncol·2009
8-other
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles.
PMID 18470481·Invest New Drugs·2008
3-trial
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.
PMID 18519777·Clin Cancer Res·2008
3-trial
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.
PMID 18235116·J Clin Oncol·2008
3-trial
Confirmation of gene expression-based prediction of survival in non-small cell lung cancer.
PMID 19088038·Clin Cancer Res·2008
8-other
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.
PMID 18235115·J Clin Oncol·2008
3-trial
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function.
PMID 17699862·Clin Cancer Res·2007
8-other
Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicin.
PMID 17908980·Clin Cancer Res·2007
3-trial
Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis.
PMID 17934353·Curr Opin Hematol·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 950 N MERIDIAN ST, SUITE 500
INDIANAPOLIS, IN 46204 - Phone
- (317) 962-5024
Quick Facts
- NPI
- 1902937949
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile